Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Oncology Practice Insider

ASCO’s Oncology Practice Insider provides the latest news, information, and educational tools to assist with the successful management of oncology practice and the delivery of high quality patient care. OPI offers updates on ASCO programs, services, and cancer-related health policy, Medicare news, and billing and coding best practices. To sign up for the biweekly Oncology Practice Insider newsletter, please complete this form.

Date
Both chambers of the United States Congress recently passed separate bills to extend the temporary moratorium on the 2% sequestration cut to Medicare reimbursement. The moratorium is currently set to expire on March 31, 2021, and both bills would extend the moratorium until December 31, 2021. However, since the House and Senate legislation differ, further action is needed before the extension becomes law.
The Health and Human Services (HHS) Office of Minority Health has partnered with the Centers for Medicare & Medicaid Services (CMS) and other HHS agencies to identify and compile multilingual resources and materials for Medicare providers to assist them in providing culturally and linguistically appropriate services. Translated resources include materials and information regarding specific diseases and conditions, health insurance, women's health topics, substance use, emergency preparedness and response, and more.
Practice Leadership Calls from ASCO’s PracticeNET program are resuming in April and May. On Thursday, April 15 from 4:00 PM–5:00 PM (ET), we will be presenting our Drug Payment Policy Primer. The call will be led by health policy specialists Allyn Moushey, MSW, Michael Francisco, MPH, Jonathan Phillips, MPH, and Karen Hagerty, MD, from ASCO’s Policy and Advocacy department. Register to join us on April 15.
ASCO’s award-winning Cancer.Net blog has been providing updated content and resources on COVID-19 for people with cancer since the pandemic started. Send your patients to the Cancer.Net blog for trusted COVID-19 information, financial resources, and more. Available in multiple languages.
In order to understand and eliminate disparities in cancer incidence and outcomes among transgender people, clinicians and researchers must have data. However, this data is very difficult to obtain because gender identity data are not routinely collected in oncology practice health records.
The Association for Clinical Oncology (ASCO) endorsed the “PREVENT HPV Cancers Act” (H.R. 1550), which was recently introduced by Representative Kathy Castor (FL-14). In a recent letter to the lawmaker, ASCO thanked Rep. Castor for introducing this important measure to increase research on, awareness of, and access to the vaccine which prevents the human papillomavirus (HPV) types that cause most types of cervical cancers as well as some other cancers.
On March 10, 2021, the Food and Drug Administration (FDA) approved tivozanib (Fotivda, AVEO Pharmaceuticals, Inc.), a kinase inhibitor, for adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies. Read more. 
On March 15, CMS is increasing the Medicare payment amount for administering the COVID-19 vaccine. This new and higher payment rate will support important actions taken by providers that are designed to increase the number of vaccines they can furnish each day, including establishing new or growing existing vaccination sites, conducting patient outreach and education, and hiring additional staff. At a time when vaccine supply is growing, CMS is supporting provider efforts to expand capacity and ensure that all Americans can be vaccinated against COVID-19 as soon as possible.